Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$453M |
| 2 |
CELG
Celgene Corp
CELG
|
+$391M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$389M |
| 4 |
GE Aerospace
GE
|
+$378M |
| 5 |
Johnson & Johnson
JNJ
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$307M |
| 2 |
Costco
COST
|
+$279M |
| 3 |
Lowe's Companies
LOW
|
+$273M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Chevron
CVX
|
+$225M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Technology | 14.11% |
| 3 | Financials | 10.92% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Real Estate | 7.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1776
Orrstown Financial Services
ORRF
$850M
| $5.35M | ﹤0.01% |
243,401
+3,940
| +2% | +$81.4K |
|
1777
Travere Therapeutics
TVTX
$5.17B
| $5.35M | ﹤0.01% |
266,300
+132,100
| +98% | +$2.61M |
|
|
ACBI
1778
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $5.34M | ﹤0.01% |
311,995
-12,713
| -4% | -$222K |
|
|
BHVN
1779
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $5.33M | ﹤0.01% |
121,800
+116,400
| +2,156% | +$6.56M |
|
1780
Perrigo
PRGO
$1.44B
| $5.32M | ﹤0.01% |
111,800
+75,500
| +208% | +$3.6M |
|
|
CHUY
1781
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $5.32M | ﹤0.01% |
232,200
-71,200
| -23% | -$1.53M |
|
1782
First Business Financial Services
FBIZ
$565M
| $5.29M | ﹤0.01% |
225,205
+15,305
| +7% | +$348K |
|
1783
Trustmark
TRMK
$2.73B
| $5.29M | ﹤0.01% |
159,004
-19,500
| -11% | -$659K |
|
1784
Napco Security Technologies
NSSC
$1.3B
| $5.28M | ﹤0.01% |
355,800
-278,600
| -44% | -$3.69M |
|
|
MSL
1785
DELISTED
Midsouth Bancorp, Inc.
MSL
| $5.28M | ﹤0.01% |
445,300
-14,700
| -3% | -$174K |
|
1786
Southern Missouri Bancorp
SMBC
$862M
| $5.26M | ﹤0.01% |
151,034
+6,900
| +5% | +$226K |
|
1787
Universal Technical Institute
UTI
$2.26B
| $5.26M | ﹤0.01% |
1,533,621
-4,135
| -0.3% | -$14K |
|
|
CBPX
1788
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $5.26M | ﹤0.01% |
197,972
-365,000
| -65% | -$9.17M |
|
1789
WillScot Mobile Mini Holdings
WSC
$4.37B
| $5.25M | ﹤0.01% |
+349,300
| New | +$4.74M |
|
1790
Terreno Realty
TRNO
$7.58B
| $5.25M | ﹤0.01% |
107,000
-95,600
| -47% | -$4.33M |
|
1791
AtriCure
ATRC
$2.08B
| $5.23M | ﹤0.01% |
175,241
+45,541
| +35% | +$1.33M |
|
1792
Rocky Brands
RCKY
$368M
| $5.22M | ﹤0.01% |
191,300
-6,800
| -3% | -$173K |
|
1793
IES Holdings
IESC
$9.89B
| $5.19M | ﹤0.01% |
275,532
+21,914
| +9% | +$397K |
|
|
HONE
1794
DELISTED
HarborOne Bancorp
HONE
| $5.19M | ﹤0.01% |
497,669
+210,553
| +73% | +$2.13M |
|
1795
Integra LifeSciences
IART
$1.28B
| $5.18M | ﹤0.01% |
+92,760
| New | +$4.78M |
|
|
INN
1796
Summit Hotel Properties
INN
$766M
| $5.17M | ﹤0.01% |
450,629
+255,629
| +131% | +$3.01M |
|
1797
Hingham Institution for Saving
HIFS
$624M
| $5.17M | ﹤0.01% |
26,100
+2,400
| +10% | +$443K |
|
|
PWOD
1798
DELISTED
Penns Woods Bancorp
PWOD
| $5.17M | ﹤0.01% |
171,203
+4,950
| +3% | +$139K |
|
1799
Nicolet Bankshares
NIC
$3.6B
| $5.16M | ﹤0.01% |
83,090
+17,000
| +26% | +$1.03M |
|
1800
iShares MSCI Brazil ETF
EWZ
$8.98B
| $5.16M | ﹤0.01% |
+117,900
| New | +$4.87M |
|
Similar funds
Renaissance Technologies's Q2 2019 Portfolio in Review
As of Q2 2019, Renaissance Technologies held 3,913 positions worth $114B, up 3.3% from $110B the previous quarter. Its ten largest holdings account for 9.1% of the portfolio.
Renaissance Technologies's Q2 2019 filing shows 495 new, 1,847 increased, 1,145 reduced and 397 closed positions. Its largest new stake was Apple: 9,290,160 shares worth $460M. The largest sale was UnitedHealth, an estimated $307M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
- Renaissance Technologies's largest Q2 2019 buy was Apple: 9,290,160 shares worth $460M.
- Renaissance Technologies added most to Celgene Corp in Q2 2019, an estimated $391M increase.
- Renaissance Technologies's biggest Q2 2019 reduction was Microsoft, cutting an estimated $230M.
- Renaissance Technologies fully exited UnitedHealth in Q2 2019, selling an estimated $307M.
- Renaissance Technologies's ten largest holdings make up 9.1% of its $114B portfolio in Q2 2019.
- Renaissance Technologies opened 495 new positions and closed 397 in Q2 2019.
- Renaissance Technologies's portfolio value rose 3.3% quarter-over-quarter to $114B.
Based on Renaissance Technologies's 13F filing for Q2 2019, filed 12 Aug 2019.